PHIO PHARMACEUTICALS CORP (PHIO) Forecast, Price Target & Analyst Ratings

NASDAQ:PHIOUS71880W5013

Current stock price

1.3 USD
+0.06 (+4.84%)
At close:
1.25 USD
-0.05 (-3.85%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PHIO PHARMACEUTICALS CORP (PHIO).

Forecast Snapshot

Consensus Price Target

Price Target
$14.28
+ 998.46% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.24
Revenue Estimate

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.28
Upside
+ 998.46%
From current price of $1.30 to mean target of $14.28, Based on 7 analyst forecasts
Low
$14.14
Median
$14.28
High
$14.70

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for PHIO. The average price target is 14.28 USD. This implies a price increase of 998.46% is expected in the next year compared to the current price of 1.3.

Analyst Ratings & History

Current Analyst Ratings

PHIO Current Analyst RatingPHIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

PHIO Historical Analyst RatingsPHIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
PHIO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PHIO.
In the previous month the buy percentage consensus was at a similar level.
PHIO was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-06-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-19HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-06HC Wainwright & Co.Maintains Buy -> Buy
2023-08-16HC Wainwright & Co.Reiterate Buy -> Buy
2021-06-14HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.24
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
2.08%
EPS (3 Months)
2.08%

Next Earnings Summary

PHIO is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.24 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
PHIO revenue by date.PHIO revenue by date.
20K140K
600.00%
20K
-85.71%

-100.00%
76.5M
EBITDA
YoY % growth
PHIO ebitda by date.PHIO ebitda by date.
-9.29M
-3.57%
-7.28M
21.64%
-8.92M
-22.53%
N/A
2.24%
N/A
-54.01%
N/A
15.19%
N/A
5.06%
N/A
31.68%
-9.486M
-28.40%
-11.118M
-17.20%
-12.24M
-10.09%
EBIT
YoY % growth
PHIO ebit by date.PHIO ebit by date.
-9.36M
-3.77%
-7.36M
21.37%
-8.99M
-22.15%
-8.976M
2.22%
-14.688M
-53.70%
-12.648M
15.17%
-12.24M
5.15%
-7.548M
32.01%
-9.467M
-28.11%
-12.105M
-27.87%
-12.954M
-7.01%
Operating Margin
PHIO operating margin by date.PHIO operating margin by date.
-46,800.00%-5,257.14%-44,950.00%N/AN/AN/A-16.00%N/AN/AN/AN/A
EPS
YoY % growth
PHIO eps by date.PHIO eps by date.
N/AN/AN/A
45.77%
-211.51
94.35%
-122.28
42.19%
-100.25
25.81%
-57.47
36.65%
-8.71
88.72%
-1.60
75.37%
-1.02
36.10%
-0.63
38.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.24-0.24
46.73%
-0.24
44.36%
-0.25
1.23%
-0.17
27.66%
-0.18
23.40%
-0.19
20.83%
-0.20
18.37%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-2.652M
-41.67%
-2.856M
-23.69%
-3.06M
-22.25%
-3.162M
-24.93%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-2.842M
-51.80%
-3.019M
-30.76%
-3.209M
-28.10%
-3.411M
-34.60%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PHIO Yearly Revenue VS EstimatesPHIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2023 20M 40M 60M
PHIO Yearly EPS VS EstimatesPHIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -50K -100K -150K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.91%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-17.49%
EBIT Next 5 Year
N/A

PHIO PHARMACEUTICALS CORP / PHIO Forecast FAQ

Can you provide the average price target for PHIO PHARMACEUTICALS CORP stock?

7 analysts have analysed PHIO and the average price target is 14.28 USD. This implies a price increase of 998.46% is expected in the next year compared to the current price of 1.3.

What is the next earnings date for PHIO stock?

PHIO PHARMACEUTICALS CORP (PHIO) will report earnings on 2026-05-13.

What are the consensus estimates for PHIO PHARMACEUTICALS CORP (PHIO) next earnings?

The consensus EPS estimate for the next earnings of PHIO PHARMACEUTICALS CORP (PHIO) is -0.24 USD and the consensus revenue estimate is 0 USD.